Kin Health Raises $9M for Patient-Facing AI Notetaker
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Kin Health raised a $9 million seed round led by Maveron, with participation from Town Hall Ventures, Eniac Ventures, Flex Capital, Foundry Square Capital, Pear VC, The Family Fund, GoodRx co-founders Doug Hirsch and Trevor Bezdek, and more than 30 physicians
- The free app records doctor visits and returns AI summaries with action items, lets users share notes with family or draft questions for future visits — distinguishing it from provider-focused rivals Heidi Health and Freed in a U.S. AI notetaker category that generated over $600 million in revenue last year, per Menlo Ventures
- Kin Health is not HIPAA-certified because the tool is patient-facing, though the company says it encrypts all patient data, keeps summaries private by default, and adheres to equivalent privacy standards
- Co-founders include physicians Arpan and Amit Parikh and Kyle Alwyn, who previously built online prescription service HeyDoctor and sold it to GoodRx; the startup will keep the app free and monetize via commissions from specialist and lab referrals, mirroring GoodRx's playbook
- Dr. Rebecca Mishuris, chief health information officer and VP at Mass General Brigham, warned that "generative AI will hallucinate" and that clinicians must review any AI-drafted notes before signing, since "the responsibility for the documentation falls to the clinician"
- Kin Health plans to integrate electronic health record (EHR) data later this year, with CEO Alwyn saying the long-term goal is a "health graph" that aggregates information from multiple sources to drive behavioral change
Why it matters: The patient-facing positioning is the key differentiator — rivals Heidi Health and Freed serve clinicians, while Kin Health bets patients will adopt a free tool and generate revenue through specialist and lab referrals, the same commission model GoodRx used to build a multi-billion-dollar business. But the explicit no-HIPAA-certification stance and Dr. Mishuris's hallucination warning from a major Boston health system highlight real trust hurdles for a consumer app handling medical advice.
